MedPath

The effect of administering high doses of intravenous vitamin C in severe traumatic brain injuries

Phase 3
Recruiting
Conditions
severe traumatic brain injuries.
Multiple injuries of head
S09.7
Registration Number
IRCT20230530058344N1
Lead Sponsor
Qazvin University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
69
Inclusion Criteria

Patient age 18 to 60 years
Patients with severe brain damage (GCS = 8)
Patients who have not undergone surgery
Informed consent of the first degree relatives of the patients and completion of the consent form

Exclusion Criteria

Chronic Kidney Disease
End-Stage Renal Disease (ESRD)
Pregnancy and breastfeeding
Hemochromatosis patients
Reluctance to cooperateIn the study
Chronic liver diseases (cirrhosis, hepatitis, etc.)
History of kidney stones
Vitamin C allergy

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Changes in the patient's clinical status and consciousness based on the GCS scale. Timepoint: At the time of entering the ICU, the second day, the fourth day and during transfer to the ward. Method of measurement: Glasgow Coma Scale.
Secondary Outcome Measures
NameTimeMethod
The duration of the patient's stay in the ICU and the hospital. Timepoint: When discharged from the hospital. Method of measurement: Counting days of hospitalization.;8 and 28 day mortality rate. Timepoint: 8 and 28 days after ICU admission. Method of measurement: Counting days of hospitalization.
© Copyright 2025. All Rights Reserved by MedPath